Sun J B, Holmgren J, Czerkinsky C
Department of Medical Microbiology and Immunology, University of Göteborg, Sweden.
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10795-9. doi: 10.1073/pnas.91.23.10795.
Oral administration of antigens, including allergens and autoantigens, may be an efficient way to prevent diseases associated with untoward immune responses to self- and non-self-antigens. However, this approach has met with limitations because it usually requires repeated administrations of large doses of antigen and is less efficient in an already immune host, and the effect is of short duration. We report that a single oral administration of minute amounts of particulate or soluble antigen coupled to the B subunit of cholera toxin (CTB) can markedly suppress systemic immune responses in naive and in systemically immune animals. Both early (2-4 hr) and late (24-48 hr) delayed type-hypersensitivity reactivities were strongly suppressed after feeding a single dose of CTB-conjugated antigen. Serum antibody responses were also decreased, although moderately, after oral administration of CTB-conjugated antigen. This strategy of tolerance induction, based on oral administration of small amounts of antigens conjugated to a mucosa-binding molecule, may find broad applications for preventing or abrogating untoward immune responses.
口服给予抗原,包括变应原和自身抗原,可能是预防与对自身和非自身抗原的不良免疫反应相关疾病的有效方法。然而,这种方法存在局限性,因为它通常需要重复给予大剂量抗原,并且在已经免疫的宿主体内效率较低,而且效果持续时间短。我们报告,单次口服微量与霍乱毒素B亚单位(CTB)偶联的颗粒状或可溶性抗原,可显著抑制未免疫动物和全身免疫动物的全身免疫反应。单次喂食CTB偶联抗原后,早期(2 - 4小时)和晚期(24 - 48小时)迟发型超敏反应均受到强烈抑制。口服CTB偶联抗原后,血清抗体反应也有适度降低。这种基于口服少量与黏膜结合分子偶联的抗原的耐受诱导策略,可能在预防或消除不良免疫反应方面有广泛应用。